Ellington Financial Inc
NYSE:EFC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
10.91
13.38
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Ellington Financial Inc
Ellington Financial Inc
Cash & Cash Equivalents
Ellington Financial Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ellington Financial Inc
NYSE:EFC
|
Cash & Cash Equivalents
$217.7m
|
CAGR 3-Years
28%
|
CAGR 5-Years
46%
|
CAGR 10-Years
5%
|
|
|
Starwood Property Trust Inc
NYSE:STWD
|
Cash & Cash Equivalents
$357.9m
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
|
Hannon Armstrong Sustainable Infrastructure Capital Inc
NYSE:HASI
|
Cash & Cash Equivalents
$44.1m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-3%
|
|
|
Annaly Capital Management Inc
NYSE:NLY
|
Cash & Cash Equivalents
$1.6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
3%
|
|
|
AGNC Investment Corp
NASDAQ:AGNC
|
Cash & Cash Equivalents
$507m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-11%
|
|
|
Rithm Capital Corp
NYSE:RITM
|
Cash & Cash Equivalents
$1.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
17%
|
CAGR 10-Years
24%
|
|
Ellington Financial Inc
Glance View
Ellington Financial Inc. is a company that operates at the intricate crossroads of finance and investment, carving out a niche for itself within the structured and diverse landscape of mortgage and other consumer-related assets. It was established with the vision of meticulously managing risk while seeking to deliver strong returns. The firm is adept at navigating the complexities inherent in residential and commercial mortgage-backed securities, deriving its strategic advantage from the keen insights and analytical prowess of its experienced team. The company utilizes a combination of proprietary models and techniques, including quantitative and qualitative analysis, to identify mispriced securities that can offer attractive risk-adjusted returns. Through its expertise in asset-backed securities, Ellington Financial charts a distinctive path, often venturing into specialized credit sectors, where traditional financial institutions might exhibit caution. This sophisticated dance through the labyrinth of financial products empowers Ellington Financial to generate income primarily through interest earnings. The firm invests in a diversified portfolio of mortgage-related and consumer-loan-related assets, leveraging these investments to capitalize on spreads between the returns on its assets and the cost of its liabilities. Furthermore, Ellington Financial practices strategic hedging to manage potential risks associated with interest rate volatility and credit risks, preserving the robustness of its investment outcomes. This focus on strategic risk management coupled with deep market insights enables Ellington Financial to sustain a resilient business model, continually adapting to an ever-evolving economic landscape while aiming to provide consistent value to its shareholders.
See Also
What is Ellington Financial Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
217.7m
USD
Based on the financial report for Sep 30, 2024, Ellington Financial Inc's Cash & Cash Equivalents amounts to 217.7m USD.
What is Ellington Financial Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
5%
Over the last year, the Cash & Cash Equivalents growth was 24%. The average annual Cash & Cash Equivalents growth rates for Ellington Financial Inc have been 28% over the past three years , 46% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
